Home > Health > Family Health > Elderly Lung Cancer Patients Can Gain From Two-Drug Chemo: Study

Elderly Lung Cancer Patients Can Gain From Two-Drug Chemo: Study

Finding runs counter to expert recommendations against use of the therapy by those over 70

August 9, 2011 RSS Feed Print

But she agreed that the new French study "moves the field forward" by highlighting the apparent "dramatic improvement in survival" among elderly afforded dual-chemo treatment.

"This strongly supports doublet chemotherapy in carefully selected older individuals with NSCLC," Reckamp said. However, "the results must be balanced by a look at the increased toxicities and deaths in the combination arm. We are still in need of addition studies that evaluate older individuals with NSCLC and perform an assessment so that we might predict those who may have greater benefit or who might be at greater risk for toxicity."

More information

For more on non-small cell lung cancer, visit the American Cancer Society.